Skip to main content

Advertisement

SpringerLink
Log in

Cancer immunotherapy meets biomaterials

  • News & Views
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Engineered biomaterials boost the efficacy of cancer vaccines and adoptive T cell therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Biomaterial scaffolds boost the efficacy of immunotherapies.

Katie Vicari/Nature Publishing Group

References

  1. Kim, J. et al. Nat. Biotechnol. 33, 64–72 (2015).

    Article  CAS  Google Scholar 

  2. Stephan, S.B. et al. Nat. Biotechnol. 33, 97–101 (2015).

    Article  CAS  Google Scholar 

  3. Ali, O.A. et al. Sci. Transl. Med. 1, 8ra19 (2009).

    Article  Google Scholar 

  4. Boissonnas, A. et al. Immunity 32, 266–278 (2010).

    Article  CAS  Google Scholar 

  5. Sharma, M.D. et al. J. Clin. Invest. 117, 2570–2582 (2007).

    Article  CAS  Google Scholar 

  6. Messina, J.L. et al. Sci Rep. 2, 765–770 (2012).

    Article  Google Scholar 

  7. Dieu-Nosjean, M.C. et al. J. Clin. Oncol. 26, 4410–4417 (2008).

    Article  CAS  Google Scholar 

  8. Melero, I. et al. Nat. Rev. Clin. Oncol. 11, 509–524 (2014).

    Article  CAS  Google Scholar 

  9. Jones, D. Nat. Rev. Drug Discov. 8, 685–686 (2009).

    Article  CAS  Google Scholar 

  10. Tran, E. et al. Science 344, 641–645 (2014)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jeffrey S. Weber & James J. Mulé are at the Moffitt Cancer Center, Tampa, Florida, USA.,

    Jeffrey S Weber & James J Mulé

Authors
  1. Jeffrey S Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James J Mulé
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey S Weber.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weber, J., Mulé, J. Cancer immunotherapy meets biomaterials. Nat Biotechnol 33, 44–45 (2015). https://doi.org/10.1038/nbt.3119

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3119

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation